• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Emergency Preparedness and Response

  • Print
  • Share
  • E-mail
-

Medical Countermeasures Initiative (MCMi)

medications, researchers in a laboratory, child getting vaccinated

-- Protecting National Health and Security

 In the Headlines

 

Click here to see poster on MCMi  

 

 

 

 

 


Sign up for Good Clinical Practice/Human Subject Protection e-mail updates Sign up for MCMi e-mail updates


About MCMi
The nation's Public Health Emergency Medical Countermeasures Enterprise identified FDA as one of its most critical components.  Strong and dynamic FDA engagement with Enterprise partners will establish clear regulatory pathways for product innovators--based on the most advanced science--and will ultimately accelerate MCM development.

Within FDA's Office of the Chief Scientist, the Office of Counterterrorism and Emerging Threats is responsible for leading the implementation of the Medical Countermeasures Initiative in close collaboration with FDA's three medical product centers--CDER, CBER, and CDRH--and the Office of Regulatory Affairs.
Read more ...

 

-
-